Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide.
$0.13-9.59%
报价 2026-11-13
市值
$10.2M
EV
$1.79B
PE (TTM)
–
预期 PE (FY2026)
0.3x
52 周区间距高点 -96.6%
$0.13$3.89
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ACHAccendra Health, Inc. | $10.2M | -9.6% | -6.8% | 44.8% | – | 7.8x | – | |
| ACRSAclaris Therapeutics, Inc. | $621.8M | -2.0% | -27.3% | 95.6% | – | – | – | |
| SGHTSight Sciences, Inc. | $601.9M | -1.5% | +19.1% | 88% | – | – | – | |
| EDITEditas Medicine, Inc. | $334.9M | +1.4% | +23.2% | 56.9% | – | – | – | |
| ALLOAllogene Therapeutics, Inc. | $290.6M | +1.4% | +1.3% | 0% | – | – | – | |
| CABACabaletta Bio, Inc. | $276.1M | -3.8% | -43.2% | 0% | – | – | – | |
| CGCCanopy Growth Corporation | $237.6M | -2.2% | – | 27.4% | – | – | – | |
| HITIHigh Tide Inc. | $220.2M | -1.2% | – | 26.5% | – | – | – | |
| BIOABioAge Labs, Inc. | $209M | -1.8% | -16.9% | 99.4% | – | – | – | |
| 同行中位数 | – | – | -7.8% | 42.1% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。